Alnylam Pharmaceuticals, Inc. (ALNY)
289.30
-1.92
(-0.66%)
USD |
NASDAQ |
Jun 11, 16:00
289.30
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Accounts Payable (Quarterly) : 126.63M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 126.63M |
| December 31, 2025 | 115.72M |
| September 30, 2025 | 117.59M |
| June 30, 2025 | 102.39M |
| March 31, 2025 | 97.40M |
| December 31, 2024 | 88.42M |
| September 30, 2024 | 70.80M |
| June 30, 2024 | 73.98M |
| March 31, 2024 | 78.15M |
| December 31, 2023 | 55.52M |
| September 30, 2023 | 73.84M |
| June 30, 2023 | 59.75M |
| March 31, 2023 | 62.24M |
| December 31, 2022 | 98.09M |
| September 30, 2022 | 40.57M |
| June 30, 2022 | 52.42M |
| March 31, 2022 | 54.92M |
| December 31, 2021 | 73.43M |
| September 30, 2021 | 40.05M |
| June 30, 2021 | 53.08M |
| March 31, 2021 | 45.38M |
| December 31, 2020 | 51.97M |
| September 30, 2020 | 27.87M |
| June 30, 2020 | 26.12M |
| March 31, 2020 | 40.48M |
| Date | Value |
|---|---|
| December 31, 2019 | 49.88M |
| September 30, 2019 | 39.39M |
| June 30, 2019 | 71.22M |
| March 31, 2019 | 22.67M |
| December 31, 2018 | 59.71M |
| September 30, 2018 | 21.77M |
| June 30, 2018 | 11.99M |
| March 31, 2018 | 13.21M |
| December 31, 2017 | 28.36M |
| September 30, 2017 | 9.239M |
| June 30, 2017 | 23.17M |
| March 31, 2017 | 25.37M |
| December 31, 2016 | 54.46M |
| September 30, 2016 | 23.14M |
| June 30, 2016 | 12.82M |
| March 31, 2016 | 17.44M |
| December 31, 2015 | 16.79M |
| September 30, 2015 | 14.27M |
| June 30, 2015 | 15.72M |
| March 31, 2015 | 15.49M |
| December 31, 2014 | 15.11M |
| September 30, 2014 | 5.201M |
| June 30, 2014 | 6.168M |
| March 31, 2014 | 5.037M |
| December 31, 2013 | 5.896M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 26.03M |
| Incyte Corp. | 228.62M |
| BioMarin Pharmaceutical, Inc. | 395.47M |
| BridgeBio Pharma, Inc. | 29.06M |
| Insmed, Inc. | 73.38M |